FDA Drug Application (020336) for DYNACIRC CR by GLAXOSMITHKLINE LLC

Back to FDA Applications sponsored by GLAXOSMITHKLINE LLC

Application Number020336
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDYNACIRC CR
Active IngredientISRADIPINE



Back to FDA Applications sponsored by GLAXOSMITHKLINE LLC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.